Lepor H - Search Results

1

Effect of finasteride and/or terazosin on serum PSA: results of VA Cooperative Study #359.

Brawer MK, Lin DW, Williford WO, Jones K, Lepor H. Brawer MK, et al. Among authors: lepor h. Prostate. 1999 Jun 1;39(4):234-9. doi: 10.1002/(sici)1097-0045(19990601)39:4<234::aid-pros3>3.0.co;2-4. Prostate. 1999. PMID: 10344212 Clinical Trial.

2

The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ. Lepor H, et al. N Engl J Med. 1996 Aug 22;335(8):533-9. doi: 10.1056/NEJM199608223350801. N Engl J Med. 1996. PMID: 8684407 Free article. Clinical Trial.

3

The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study.

Lepor H, Jones K, Williford W. Lepor H, et al. J Urol. 2000 Apr;163(4):1134-7. J Urol. 2000. PMID: 10737482 Clinical Trial.

4

The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

Lepor H, Williford WO, Barry MJ, Haakenson C, Jones K. Lepor H, et al. J Urol. 1998 Oct;160(4):1358-67. J Urol. 1998. PMID: 9751354 Clinical Trial.

5

Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?

Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, Lepor H. Barry MJ, et al. Among authors: lepor h. J Urol. 1995 Nov;154(5):1770-4. doi: 10.1016/s0022-5347(01)66780-6. J Urol. 1995. PMID: 7563343

6

Filling and voiding symptoms in the American Urological Association symptom index: the value of their distinction in a Veterans Affairs randomized trial of medical therapy in men with a clinical diagnosis of benign prostatic hyperplasia.

Barry MJ, Williford WO, Fowler FJ Jr, Jones KM, Lepor H. Barry MJ, et al. Among authors: lepor h. J Urol. 2000 Nov;164(5):1559-64. J Urol. 2000. PMID: 11025704

7

Study design of the Medical Therapy of Prostatic Symptoms (MTOPS) trial.

Bautista OM, Kusek JW, Nyberg LM, McConnell JD, Bain RP, Miller G, Crawford ED, Kaplan SA, Sihelnik SA, Brawer MK, Lepor H. Bautista OM, et al. Among authors: lepor h. Control Clin Trials. 2003 Apr;24(2):224-43. doi: 10.1016/s0197-2456(02)00263-5. Control Clin Trials. 2003. PMID: 12689743 Clinical Trial.

8

Letter from the editors of reviews in urology.

Brawer MK, Lepor H. Brawer MK, et al. Among authors: lepor h. Rev Urol. 2001 Spring;3(2):e110. Rev Urol. 2001. PMID: 16985692 Free PMC article. No abstract available.

9

Readership survey: reviews in urology.

Brawer MK, Lepor H. Brawer MK, et al. Among authors: lepor h. Rev Urol. 2001 Summer;3(3):111-2. Rev Urol. 2001. PMID: 16985702 Free PMC article. No abstract available.

10

The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPH.

Lepor H, Machi G. Lepor H, et al. Prostate. 1992;20(2):89-95. doi: 10.1002/pros.2990200203. Prostate. 1992. PMID: 1372430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

445 results

Search Page

Filters